Downregulation of Serum miR-133b and miR-206 Associate with Clinical Outcomes of Progression as Monitoring Biomarkers for Metastasis Colorectal Cancer Patients.

Surasak Wanram Namphon KlaewklaParichart Pinyosri

Published in: MicroRNA (Shariqah, United Arab Emirates) (2024)

The circulating serum miR-133b and miR-206 can serve as significant biomarkers for monitoring the clinical outcome of progression with metastatic CRC patients. Increased drug-responsive CRC patients associated with crucial molecular intervention should be further explored, clinically.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
cell proliferation
randomized controlled trial
peritoneal dialysis
long non coding rna
small cell lung cancer
emergency department
patient reported outcomes
long noncoding rna
patient reported